Deguan Lv Selected Research

apelin-13 peptide

10/2018	ROS-Autophagy pathway mediates monocytes-human umbilical vein endothelial cells adhesion induced by apelin-13.
5/2016	PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13.
2/2016	Apelin-13 induces autophagy in hepatoma HepG2 cells through ERK1/2 signaling pathway-dependent upregulation of Beclin1.
12/2015	Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy.
2/2014	ERK1/2 mediates lung adenocarcinoma cell proliferation and autophagy induced by apelin-13.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deguan Lv Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 05/2016
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2017
6	Carcinogenesis 09/2021 - 11/2017
3	Adenocarcinoma of Lung 09/2021 - 02/2014
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 02/2016
2	Atherosclerosis 10/2018 - 07/2013
2	Lung Neoplasms (Lung Cancer) 05/2016 - 02/2014
1	Leukemia 01/2022
1	Glioma (Gliomas) 01/2019
1	Atherosclerotic Plaque (Atheroma) 10/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Hypoxia (Hypoxemia) 05/2016
1	Adenocarcinoma 05/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2015
1	Hypertrophy 12/2015

Drug/Important Bio-Agent (IBA)

6	ApelinIBA 09/2021 - 07/2013
5	apelin-13 peptideIBA 10/2018 - 02/2014
3	Histones (Histone)IBA 01/2022 - 11/2017
3	Lysine (L-Lysine)FDA Link 01/2022 - 11/2017
2	ChromatinIBA 01/2022 - 11/2017
2	6-methyladenineIBA 01/2022 - 01/2020
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 11/2021
2	N-methyladenosineIBA 01/2022 - 01/2020
2	Beclin-1IBA 09/2021 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2015
2	Actin Depolymerizing Factors (Cofilins)IBA 09/2021 - 05/2016
1	histone H3 trimethyl Lys4IBA 01/2022
1	Histone MethyltransferasesIBA 01/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022
1	Platelet-Derived Growth FactorIBA 01/2022
1	Histone-Lysine N-MethyltransferaseIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2022
1	Growth Factor ReceptorsIBA 01/2022
1	RolipramIBA 01/2022
1	Phosphodiesterase 4 InhibitorsIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 11/2021
1	Autophagy-Related ProteinsIBA 09/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 10/2018
1	beta CateninIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 11/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2017
1	Lysine AcetyltransferasesIBA 11/2017
1	Tripartite Motif ProteinsIBA 11/2017
1	ErbB Receptors (EGF Receptor)IBA 11/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 05/2016
1	AdipokinesIBA 05/2016
1	Peptides (Polypeptides)IBA 05/2016
1	LigandsIBA 05/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2016
1	RazoxaneIBA 05/2016
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 12/2015
1	ImmunosorbentsIBA 02/2014
1	EnzymesIBA 02/2014

Therapy/Procedure

3	Therapeutics 01/2022 - 05/2016
2	Immunotherapy 01/2022 - 01/2022